Vedolizumab was safe and showed superiority over infliximab as first-line biologic therapy in the management of patients with UC.

Rectal neoplasms extending to the dentate line can be safely and effectively managed with endoscopic submucosal dissection.

GLP-1RA dispensing has increased from 2022 and 2023, whereas metabolic bariatric surgery has decreased among individuals with obesity.

Gastric cancer detection rates may improve, though at an inconsistent rate, with computer-aided detection in EGD.

Compared with men, women who switched to INSTI-based ART for HIV management experienced greater weight gain over 5 years.

American seniors still pay more for health care than their counterparts in most other wealthy countries do, despite coverage by Medicare.

Colorectal cancer risk factors are important to consider when making decisions for colonoscopy rescreening following negative results.

Researchers confirmed the long-term safety profile of ozanimod for the treatment of moderate to severe UC or RMS.

Patients with inflammatory bowel disease (IBD) or primary sclerosing cholangitis (PSC) show promising outcomes when receiving advanced therapies following liver transplantation, according to study ...

No significant difference in the risk for MACE was observed between patients with IBD receiving JAK vs TNF inhibitors.

Ileosigmoid fistulas in Crohn disease are surgically managed in varying ways, which suggests a need for standardized guidelines.

Hidradenitis suppurativa is more common among patients with Crohn disease (CD) than ulcerative colitis (UC), yet bowel obstruction affects both CD and UC.